🕵️ Crispr Therapeutics AG ($CRSP)
SEC insider & ownership activity, last 12 months · CIK 1674416 · every row links its SEC filing
Over the last 12 months insiders sold $17.6M against $1.2M of open-market buying. Kulkarni Samarth sold $11.5M (Aug–Mar). ARK Investment Management LLC added 8.8% → 10.5%. No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $1.2M (2 lots) · 4 sellers, $17.6M (27 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Kulkarni Samarth | 0 | – | 10 | $11.5M | Mar 23, 2026 |
| Prasad Raju | 0 | – | 10 | $5.1M | Mar 23, 2026 |
| Douglas A. Treco | 1 | $1.1M | 0 | – | Aug 6, 2025 |
| James R. Kasinger | 0 | – | 5 | $646K | Mar 23, 2026 |
| Patel Naimish | 1 | $50K | 2 | $363K | May 29, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 11.8% | 13G | Apr 30, 2026 | filing ↗ | |
| Catherine D. Wood | 11.8% | 13G | Apr 30, 2026 | filing ↗ | |
| ARK Investment Management LLC | 10.5% | 13G | Feb 14, 2025 | filing ↗ | |
| Blackrock, Inc. | 8.3% | 13G | Jul 27, 2026 | filing ↗ | |
| Orbis Investment Management Ltd | 6.3% | 13G | May 15, 2026 | filing ↗ | |
| Capital World Investors | 5.1% | 13G | May 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Samarth Kulkarni | $3.6M | Jan 22, 2026 | filing ↗ |
| Raju Prasad | $2.1M | Jan 22, 2026 | filing ↗ |
| Samarth Kulkarni | $1.6M | Jan 20, 2026 | filing ↗ |
| Raju Prasad | $1.8M | Jan 6, 2026 | filing ↗ |
| Raju Prasad | $560K | Dec 22, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 4, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 4, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing ↗ |
| Earnings (2.02) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 16, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 16, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing ↗ |
| Other events (8.01) | Mar 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing ↗ |
| Earnings (2.02) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |
| Other events (8.01) | Jan 12, 2026 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Other events (8.01) | Oct 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 15, 2025 | filing ↗ |
| Earnings (2.02) | Aug 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 4, 2025 | filing ↗ |